About Us

Our Mission

Today, many patients with sickle cell (who are mostly in the African American, and Hispanic communities) spend up to a million dollars in total healthcare costs by the age of 45 years. Frequent hospital visits and hospitalization also affects the total lifetime earnings of sickle cell disease patients. KovaDx is making the diagnosis and monitoring of sickle cell disease patients faster, easier to perform, and more affordable.

We believe that regardless of income or circumstances of birth, no one should have to forgo healthcare due to a lack of resources. Starting with Sickle Cell Disease, our vision is to apply our proprietary 3D phase imaging microscope and deep learning algorithms to solve the world’s biggest global health problems including sickle cell, malaria, and blood cancers.

We've received funding and support from...

Advisors

  • Adam Wax, Ph.D.
  • Duke University
  • Scientific Advisory
  • Smita Krishnaswamy, Ph.D.
  • Yale University
  • Scientific Advisory
  • Colin Foster, MBA
  • Yale University
  • Business Advisory
  • Denise Winokur, Ph.D.
  • University of Pennsylvania
  • Business Advisory
  • Thomas Gerson, MBA
  • ElabNYC
  • Business Advisory
  • Kagya Amoako, Ph.D
  • University of New Haven
  • Scientific Advisory